Scientific Advisory Board
-
Jeffrey Cummings MD
Director of Cleveland Clinic Lou Ruvo Center for Brain Health and Professor of Neurotherapeutics and Drug Development, Cleveland Clinic.
-
Hoau-Yan Wang PhD
Tenured Medical Professor at CUNY Medical School; co-lead scientist on discovery & development of simufilam and SavaDx.
-
Steven E. Arnold MD
Translational Neurology Head of the Interdisciplinary Brain Center, Massachusetts General Hospital, Harvard Medical School.
-
Trevor W. Robbins CBE FRS FMedSci
Professor of Cognitive Neuroscience at the University of Cambridge and Past President of the British Neuroscience Association.
-
Barbara J. Sahakian FBA, FMedSci
Professor of Clinical Neuropsychology at the Department of Psychiatry and Medical Research Council /Wellcome Trust Behavioral and Clinical Neuroscience Institute, University of Cambridge.
-
Robert Gussin PhD
Dr. Gussin worked at Johnson & Johnson for 26 years, most recently as Chief Scientific Officer and Corporate Vice President, Science and Technology from 1986 through his retirement in 2000.
-
Patrick Scannon MD, PhD
Founder and former previous Executive Vice President, Chief Biotechnology Officer of Xoma Corporation.